{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:15:14Z","timestamp":1791008114088,"version":"4.1.0"},"reference-count":159,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":533,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["AG028072"],"award-info":[{"award-number":["AG028072"]}]},{"name":"NIH","award":["RR00163"],"award-info":[{"award-number":["RR00163"]}]},{"DOI":"10.13039\/100000957","name":"Alzheimer Association","doi-asserted-by":"crossref","award":["IIRG-09-92429"],"award-info":[{"award-number":["IIRG-09-92429"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.bbadis.2011.10.016","type":"journal-article","created":{"date-parts":[[2011,11,5]],"date-time":"2011-11-05T19:42:45Z","timestamp":1320522165000},"page":"101-110","source":"Crossref","is-referenced-by-count":170,"title":["Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease"],"prefix":"10.1016","volume":"1822","author":[{"given":"P. Hemachandra","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulziibat P.","family":"Shirendeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2011.10.016_bb0005","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0830","series-title":"Huntington's Disease","author":"Folstein","year":"1990"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0015","first-page":"21","article-title":"Brain imaging and cognitive dysfunctions in Huntington's disease","volume":"31","author":"Montoya","year":"2006","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0835","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0025","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1212\/WNL.23.6.561","article-title":"Huntington's disease in children: neuropathologic study of four cases","volume":"23","author":"Byers","year":"1973","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0030","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/jnnp.56.5.487","article-title":"Neuronal loss in the hippocampus in Huntington's disease: a comparison with HIV infection","volume":"56","author":"Spargo","year":"1993","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0035","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1093\/brain\/awn244","article-title":"Hypothalamic involvement in Huntington's disease: an in vivo PET study","volume":"131","author":"Politis","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0840","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.nbd.2010.07.013","article-title":"Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis","volume":"40","author":"Soneson","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0045","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0050","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0055","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0060","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0845","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/2510","article-title":"Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA","volume":"20","author":"Reddy","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0850","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0075","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","article-title":"A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration","volume":"23","author":"Hodgson","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0080","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F","article-title":"Enhanced sensitivity to N-methyl-d-aspartate receptor activation in transgenic and knock-in mouse models of Huntington's disease","volume":"58","author":"Levine","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0085","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/hmg\/8.1.115","article-title":"Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse","volume":"8","author":"Wheeler","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","article-title":"Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease","volume":"101","author":"Yamamoto","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brainresrev.2009.04.001","article-title":"Mitochondrial structural and functional dynamics in Huntington's disease","volume":"61","author":"Reddy","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0100","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1093\/hmg\/ddq306","article-title":"Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease","volume":"19","author":"Kim","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0105","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/hmg\/ddr024","article-title":"Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage","volume":"20","author":"Shirendeb","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0855","article-title":"Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease","author":"Shirendeb","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0115","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nm.2313","article-title":"Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity","volume":"17","author":"Song","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0120","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0166-2236(99)01415-0","article-title":"Recent advances in understanding the pathogenesis of Huntington's disease","volume":"22","author":"Reddy","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0125","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0130","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1074\/jbc.M103946200","article-title":"Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C terminal binding protein, and represses transcription","volume":"277","author":"Kegel","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0135","doi-asserted-by":"crossref","first-page":"36464","DOI":"10.1074\/jbc.M503672200","article-title":"Huntingtin associates with acidic phospholipids at the plasma membrane","volume":"280","author":"Kegel","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0140","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0145","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/hmg\/ddh162","article-title":"Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release","volume":"13","author":"Choo","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0150","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1139\/o06-181","article-title":"Hypothesis: huntingtin may function in membrane association and vesicular trafficking","volume":"84","author":"Truant","year":"2006","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0155","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/hmg\/ddl467","article-title":"Wild-type huntingtin participates in protein trafficking between the Golgi and the extracellular space","volume":"16","author":"Strehlow","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0160","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1093\/hmg\/ddm217","article-title":"Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity","volume":"16","author":"Atwal","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0165","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1523\/JNEUROSCI.0106-08.2008","article-title":"N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking","volume":"28","author":"Orr","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0170","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.neuro.23.1.217","article-title":"Glutamine repeats and neurodegeneration","volume":"23","author":"Zoghbi","year":"2000","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0175","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/nsmb860","article-title":"Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer","volume":"11","author":"Wacker","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0180","doi-asserted-by":"crossref","first-page":"41032","DOI":"10.1074\/jbc.M205809200","article-title":"Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrilization","volume":"277","author":"Poirier","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0185","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nsmb.1570","article-title":"Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism","volume":"16","author":"Thakur","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0190","doi-asserted-by":"crossref","first-page":"21647","DOI":"10.1074\/jbc.M109.016923","article-title":"Monoclonal antibodies recognize distinct conformational epitopes formed by polyglutamine in a mutant huntingtin fragment","volume":"284","author":"Legleiter","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0195","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/hmg\/ddp467","article-title":"Identical oligomeric and fibrillary structures captured from the brains of R6\/2 and knock-in mouse models of Huntington's disease","volume":"19","author":"Sathasivam","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0200","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0860","article-title":"A\u03b2 oligomer directly modulates P\/Q-type calcium currents in Xenopus oocytes","author":"Mezler","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0865","doi-asserted-by":"crossref","DOI":"10.1039\/c1an15480j","article-title":"Optical trapping for the characterization of amyloid-beta aggregation kinetics","author":"Veloso","year":"2011","journal-title":"Analyst"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0870","doi-asserted-by":"crossref","DOI":"10.1007\/s11626-011-9439-y","article-title":"The effects of amyloid-\u03b2(42) oligomer on the proliferation and activation of astrocytes in vitro","author":"Hou","year":"2011","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0220","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1742-2094-8-93","article-title":"ELISA measurement of specific non-antigen-bound antibodies to A\u03b21\u201342 monomer and soluble oligomers in sera from Alzheimer's disease, mild cognitively impaired, and noncognitively impaired subjects","volume":"8","author":"Klaver","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0225","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1093\/hmg\/ddr139","article-title":"Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage","volume":"20","author":"Manczak","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0230","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1212\/WNL.0b013e318219dd92","article-title":"Detection of elevated levels of \u03b1-synuclein oligomers in CSF from patients with Parkinson disease","volume":"77","author":"Bruggink","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0235","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jns.2011.04.015","article-title":"Proteasome inhibition induces \u03b1-synuclein SUMOylation and aggregate formation","volume":"307","author":"Kim","year":"2011","journal-title":"J. Neurol. Sci."},{"issue":"Suppl. 2","key":"10.1016\/j.bbadis.2011.10.016_bb0875","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3233\/JAD-2011-110182","article-title":"Targeting oligomers in neurodegenerative disorders: lessons from \u03b1-synuclein, tau, and amyloid-\u03b2 peptide","volume":"24","author":"Gadad","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0880","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.febslet.2011.03.046","article-title":"Inhibition and disaggregation of \u03b1-synuclein oligomers by natural polyphenolic compounds","volume":"585","author":"Caruana","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0250","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1471-4159.2011.07254.x","article-title":"AMPA-receptor-mediated excitatory synaptic transmission is enhanced by iron-induced \u03b1-synuclein oligomers","volume":"117","author":"H\u00fcls","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0255","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3858\/emm.2011.43.4.026","article-title":"Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers","volume":"43","author":"Lee","year":"2011","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0260","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1073\/pnas.1013225108","article-title":"Low-resolution structure of a vesicle disrupting \u03b1-synuclein oligomer that accumulates during fibrillation","volume":"108","author":"Giehm","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0265","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.molcel.2006.08.017","article-title":"Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers","volume":"23","author":"Behrends","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0270","doi-asserted-by":"crossref","first-page":"16888","DOI":"10.1074\/jbc.M601470200","article-title":"The two-stage pathway of ataxin-3 fibrillogenesis involves a polyglutamine-independent step","volume":"281","author":"Ellisdon","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0275","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/ncb1478","article-title":"Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state","volume":"8","author":"Kitamura","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0280","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nsmb1215","article-title":"A toxic monomeric conformer of the polyglutamine protein","volume":"14","author":"Nagai","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0285","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature01301","article-title":"Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders","volume":"421","author":"S\u00e1nchez","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0290","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.molcel.2004.06.029","article-title":"Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation","volume":"15","author":"Schaffar","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0295","doi-asserted-by":"crossref","first-page":"24039","DOI":"10.1074\/jbc.M704789200","article-title":"Detection of polyglutamine protein oligomers in cells by fluorescence correlation spectroscopy","volume":"282","author":"Takahashi","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0300","doi-asserted-by":"crossref","first-page":"34717","DOI":"10.1074\/jbc.M209852200","article-title":"Expansion of polyglutamine induces the formation of quasi-aggregate in the early stage of protein fibrillization","volume":"278","author":"Tanaka","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0305","doi-asserted-by":"crossref","first-page":"e15245","DOI":"10.1371\/journal.pone.0015245","article-title":"Formation and toxicity of soluble polyglutamine oligomers in living cells","volume":"5","author":"Lajoie","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0310","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.nbd.2006.12.010","article-title":"Phenotypic abnormalities in the YAC128 mouse model of Huntington disease are penetrant on multiple genetic backgrounds and modulated by strain","volume":"26","author":"Van Raamsdonk","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0885","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/B:SCAM.0000007124.19463.e5","article-title":"Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins","volume":"24","author":"Huang","year":"1998","journal-title":"Somat. Cell Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0890","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1083\/jcb.143.6.1457","article-title":"Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation","volume":"143","author":"Perez","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0335","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/79139","article-title":"Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription","volume":"26","author":"Shimohata","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0340","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1385\/NMM:7:4:297","article-title":"Interaction of the nuclear matrix protein NAKAP with HypA and huntingtin: implications for nuclear toxicity in Huntington's disease pathogenesis","volume":"7","author":"Sayer","year":"2005","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0345","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1007\/s00018-006-6242-0","article-title":"Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies","volume":"63","author":"Borrell-Pag\u00e8s","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0350","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1523\/JNEUROSCI.20-10-03705.2000","volume":"20","author":"Rigamonti","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0355","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/hmg\/10.10.1049","article-title":"Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release","volume":"10","author":"Jana","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0895","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.cdd.4401358","article-title":"Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease","volume":"11","author":"Hermel","year":"2004","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0365","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1471-4159.2008.05734.x","article-title":"Allele-specific silencing of mutant Huntington's disease gene","volume":"108","author":"Zhang","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0370","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s10571-007-9220-7","article-title":"Increased caspase-2, calpain activations and decreased mitochondrial complex II activity in cells expressing exogenous huntingtin exon 1 containing CAG repeat in the pathogenic range","volume":"27","author":"Majumder","year":"2007","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0375","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1093\/hmg\/ddn139","volume":"17","author":"Warby","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0380","doi-asserted-by":"crossref","first-page":"24713","DOI":"10.1074\/jbc.M103501200","article-title":"Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-d-aspartate receptors via post-synaptic density 95","volume":"276","author":"Sun","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0385","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1523\/JNEUROSCI.21-23-09112.2001","article-title":"Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease","volume":"21","author":"Laforet","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0390","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s100720170047","article-title":"An abnormal striatal synaptic plasticity may account for the selective neuronal vulnerability in Huntington's disease","volume":"22","author":"Centonze","year":"2001","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0900","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pneurobio.2004.02.002","article-title":"Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington's disease","volume":"72","author":"Lee","year":"2004","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0400","doi-asserted-by":"crossref","first-page":"13614","DOI":"10.1523\/JNEUROSCI.3455-07.2007","article-title":"Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA induced apoptosis in YAC128 model of Huntington's disease","volume":"27","author":"Fernandes","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0405","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11010-005-3454-9","article-title":"Ca2+-induced permeability transition in human lymphoblastoid cell mitochondria from normal and Huntington's disease individuals","volume":"269","author":"Panov","year":"2005","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0410","doi-asserted-by":"crossref","first-page":"11174","DOI":"10.1523\/JNEUROSCI.3004-06.2006","article-title":"Mitochondrial-dependent Ca2+ handling in Huntington's disease striatal cells: effect of histone deacetylase inhibitors","volume":"26","author":"Oliveira","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0415","doi-asserted-by":"crossref","first-page":"34785","DOI":"10.1074\/jbc.M603845200","article-title":"Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences","volume":"281","author":"Milakovic","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0420","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/hmg\/ddl440","article-title":"The first 17 amino acids of huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis","volume":"16","author":"Rockabrand","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0425","doi-asserted-by":"crossref","first-page":"30715","DOI":"10.1074\/jbc.M709555200","article-title":"Impaired regulation of brain mitochondria by extramitochondrial Ca2+ in transgenic Huntington disease rats","volume":"283","author":"Gellerich","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0430","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1074\/jbc.M704704200","article-title":"Calcium homeostasis and mitochondrial dysfunction in striatal neurons of Huntington disease","volume":"283","author":"Lim","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0435","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1074\/jbc.M807459200","article-title":"In situ mitochondrial Ca2+ buffering differences of intact neurons and astrocytes from cortex and striatum","volume":"284","author":"Oliveira","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0905","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia","volume":"41","author":"Browne","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0455","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","article-title":"Biochemical abnormalities and excitotoxicity in Huntington's disease brain","volume":"45","author":"Tabrizin","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0460","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1128\/MCB.24.18.8195-8209.2004","article-title":"Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro","volume":"24","author":"Trushina","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0910","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.nbd.2005.12.007","article-title":"Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons","volume":"22","author":"Chang","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0475","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archneur.58.2.273","article-title":"Progression of symptoms in the early and middle stages of Huntington disease","volume":"58","author":"Kirkwood","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0480","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1212\/01.WNL.0000086373.32347.16","article-title":"Huntington's disease: clinical correlates of disability and progression","volume":"61","author":"Mahant","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0485","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/hmg\/ddn428","article-title":"Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse models","volume":"18","author":"Phan","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0490","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1212\/01.wnl.0000334276.09729.0e","article-title":"Weight loss in Huntington disease increases with higher CAG repeat number","volume":"71","author":"Aziz","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0495","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1212\/WNL.39.6.796","article-title":"Clinical\u2013pathologic correlation in Huntington's disease: a neuropsychological and computed tomography study","volume":"39","author":"Bamford","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0500","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1212\/WNL.44.5.823","article-title":"Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons","volume":"44","author":"Aylward","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0505","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0006-3223(91)90211-4","article-title":"Cerebral structure on MRI, part II: specific changes in Alzheimer's and Huntington's diseases","volume":"29","author":"Jernigan","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0510","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1001\/archneur.1996.00550040044013","article-title":"Single photon emission computed tomographic blood flow and magnetic resonance volume imaging of basal ganglia in Huntington's disease","volume":"53","author":"Harris","year":"1996","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0515","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1212\/WNL.48.2.394","article-title":"Longitudinal change in basal ganglia volume in patients with Huntington's disease","volume":"48","author":"Aylward","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0520","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410120504","article-title":"Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan","volume":"12","author":"Kuhl","year":"1982","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0525","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ana.410200305","article-title":"PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline","volume":"20","author":"Young","year":"1986","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0530","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1212\/WNL.36.7.888","article-title":"Positron emission tomography in the early diagnosis of Huntington's disease","volume":"36","author":"Hayden","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0535","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/brain\/113.5.1405","article-title":"Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease","volume":"113","author":"Kuwert","year":"1990","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0540","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1073\/pnas.0609833104","article-title":"Selective defect of in vivo glycolysis in early Huntington's disease striatum","volume":"104","author":"Powers","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0545","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1471-4159.2007.04996.x","article-title":"Mitochondrial NAD+-linked state 3 respiration and complex-I activity are compromised in the cerebral cortex of 3-nitropropionic acid-induced rat model of Huntington's disease","volume":"104","author":"Pandey","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0550","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1093\/hmg\/ddi319","article-title":"HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism","volume":"14","author":"Seong","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0555","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev.cellbio.22.010305.104638","article-title":"Mitochondrial fusion and fission in mammals","volume":"22","author":"Chan","year":"2006","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0560","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1089\/ars.2007.1754","article-title":"Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons","volume":"9","author":"Reddy","year":"2007","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0565","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1196\/annals.1427.030","article-title":"Impairing the mitochondrial fission and fusion balance: a new mechanism of neurodegeneration","volume":"1147","author":"Knott","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0570","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brainresrev.2009.04.001","article-title":"Mitochondrial structural and functional dynamics in Huntington's disease","volume":"61","author":"Reddy","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0575","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brainresrev.2010.11.004","article-title":"Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases","volume":"67","author":"Reddy","year":"2011","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0580","doi-asserted-by":"crossref","first-page":"19318","DOI":"10.1073\/pnas.0804871105","article-title":"Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission\/fusion proteins","volume":"105","author":"Wang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0585","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1523\/JNEUROSCI.1357-09.2009","article-title":"Impaired balance of mitochondrial fission and fusion in Alzheimer's disease","volume":"29","author":"Wang","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0590","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1093\/hmg\/ddr139","article-title":"Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage","volume":"20","author":"Manczak","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0915","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1093\/hmg\/ddr381","article-title":"Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease","volume":"20","author":"Calkins","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0600","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1474-9726.2011.00721.x","article-title":"DLP1-dependent mitochondrial fragmentation mediates 1-methyl-4-phenylpyridinium toxicity in neurons: implications for Parkinson's disease","volume":"10","author":"Wang","year":"2011","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0605","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3233\/JAD-2005-7203","article-title":"Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction","volume":"7","author":"Reddy","year":"2005","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0610","doi-asserted-by":"crossref","first-page":"18670","DOI":"10.1073\/pnas.1006586107","article-title":"Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model","volume":"107","author":"Du","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0615","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1750-1326-5-55","article-title":"\u03b1-Synuclein induced synapse damage is enhanced by amyloid-\u03b21\u201342","volume":"5","author":"Bate","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0920","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1007\/s10495-010-0476-x","article-title":"Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer's and Parkinson's diseases","author":"Nakamura","year":"2010","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0625","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.expneurol.2007.05.022","article-title":"Cell systems and the toxic mechanism(s) of alpha-synuclein","volume":"209","author":"Cookson","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0630","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.molbrainres.2004.11.007","article-title":"Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures","volume":"134","author":"Testa","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0635","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.neuroscience.2005.01.007","article-title":"Evidence of a breakdown of corticostriatal connections in Parkinson's disease","volume":"132","author":"Stephens","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0925","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1042\/BST0380488","article-title":"Presynaptic dysfunction in Huntington's disease","volume":"38","author":"Rozas","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0650","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbr.2008.11.037","article-title":"Targeting oxidative\/nitrergic stress ameliorates motor impairment, and attenuates synaptic mitochondrial dysfunction and lipid peroxidation in two models of Huntington's disease","volume":"199","author":"P\u00e9rez-De La Cruz","year":"2009","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.bbadis.2011.10.016_bb0655","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/cdd.2010.127","article-title":"Dendritic spine loss and neurodegeneration is rescued by Rab11 in models of Huntington's disease","volume":"18","author":"Richards","year":"2011","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0660","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1100\/tsw.2010.164","article-title":"Role of adenosine A(2A) receptors in modulating synaptic functions and brain levels of BDNF: a possible key mechanism in the pathophysiology of Huntington's disease","volume":"10","author":"Tebano","year":"2010","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0665","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1523\/JNEUROSCI.3539-10.2011","article-title":"Differential electrophysiological changes in striatal output neurons in Huntington's disease","volume":"31","author":"Andr\u00e9","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0670","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1261\/rna.1062908","article-title":"Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAs","volume":"14","author":"Boudreau","year":"2008","journal-title":"RNA"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0675","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mt.2009.17","article-title":"Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0930","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1073\/pnas.0801775105","article-title":"Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi","volume":"105","author":"McBride","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0685","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/mt.2008.231","article-title":"Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0690","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.cub.2009.03.030","article-title":"Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients","volume":"19","author":"Pfister","year":"2009","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0695","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/nmeth.1261","article-title":"Linking SNPs to CAG repeat length in Huntington's disease patients","volume":"5","author":"Liu","year":"2008","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0700","doi-asserted-by":"crossref","first-page":"17204","DOI":"10.1073\/pnas.0708285104","article-title":"Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits","volume":"104","author":"DiFiglia","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0705","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1371\/journal.pgen.0020140","article-title":"Designing siRNA that distinguish between genes that differ by a single nucleotide","volume":"2","author":"Schwarz","year":"2006","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0710","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/sj.gt.3302726","article-title":"Target selectivity in mRNA silencing","volume":"13","author":"Aronin","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0715","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1172\/JCI45130","article-title":"Oligonucleotide therapeutic approaches for Huntington disease","volume":"121","author":"Sah","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0720","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/1073858410386236","article-title":"Gene therapy in mouse models of Huntington disease","volume":"17","author":"Southwell","year":"2011","journal-title":"Neuroscientist"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0935","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1093\/hmg\/ddr137","article-title":"RNAi medicine for the brain: progresses and challenges","volume":"20","author":"Boudreau","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0940","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1073\/pnas.0501507102","article-title":"RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model","volume":"102","author":"Harper","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0735","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0945","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","article-title":"Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration","volume":"4","author":"Weydt","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0745","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators","volume":"127","author":"St-Pierre","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0750","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/cdd.2008.110","article-title":"Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies","volume":"16","author":"Sarkar","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0755","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.mam.2006.08.008","article-title":"Role of autophagy in the clearance of mutant huntingtin: a step towards therapy?","volume":"27","author":"Ravikumar","year":"2006","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0760","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0070-2153(06)76003-3","article-title":"Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications","volume":"76","author":"Williams","year":"2006","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0765","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4161\/auto.2696","article-title":"Protective roles for induction of autophagy in multiple proteinopathies","volume":"2","author":"Menzies","year":"2006","journal-title":"Autophagy"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0770","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/hmg\/ddi458","article-title":"Rapamycin alleviates toxicity of different aggregate-prone proteins","volume":"15","author":"Berger","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0775","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/hmg\/11.9.1107","article-title":"Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy","volume":"11","author":"Ravikumar","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0780","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/hmg\/ddg109","article-title":"Raised intracellular glucose concentrations reduce aggregation and cell death caused by mutant huntingtin exon 1 by decreasing mTOR phosphorylation and inducing autophagy","volume":"12","author":"Ravikumar","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0785","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0790","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/hmg\/ddl036","article-title":"Rapamycin pre-treatment protects against apoptosis","volume":"15","author":"Ravikumar","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0795","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/nbdi.2001.0406","article-title":"Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease","volume":"8","author":"Andreassen","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0800","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1523\/JNEUROSCI.20-12-04389.2000","article-title":"Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease","volume":"20","author":"Ferrante","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0805","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3940(01)02326-6","article-title":"Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington's disease transgenic mouse model","volume":"315","author":"Schilling","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0810","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/ng1534","article-title":"Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons","volume":"37","author":"Parker","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0815","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(08)61074-0","article-title":"Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study","volume":"372","author":"Doody","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2011.10.016_bb0820","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1358\/dnp.2010.23.8.1500435","article-title":"The rise and fall of Dimebon","volume":"23","author":"Bezprozvanny","year":"2010","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.bbadis.2011.10.016_bb0825","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archneurol.2009.334","article-title":"A randomized, placebo-controlled trial of latrepirdine in Huntington disease","volume":"67","author":"Kieburtz","year":"2010","journal-title":"Arch. Neurol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443911002493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443911002493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T12:58:22Z","timestamp":1713099502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443911002493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":159,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0925443911002493"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2011.10.016","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}